A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
about
New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunityAutologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience."Cure" for multiple sclerosis (MS)-Evolving views of therapy goals in patients on different stages of the disease: A pilot study in a cohort of Polish MS patientsHematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.Aggressive multiple sclerosis: proposed definition and treatment algorithm.Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis.The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim reportHigh-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.Autologous bone marrow transplantation for the treatment of multiple sclerosis.Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Autologous hematopoietic stem cell transplantation (AHSCT) for aggressive multiple sclerosis - whom, when and how.Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions.Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.Cell Therapy for Multiple Sclerosis.Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study.Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosisAutologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis.Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant multiple sclerosis.Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party.Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis.Cell-based therapeutic strategies for multiple sclerosis.Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.Progress and prospects for the use and the understanding of the mode of action of autologous hematopoietic stem cell transplantation in the treatment of multiple sclerosis.NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.Updated views on autologous hematopoietic stem cell transplantation for treatment of multiple sclerosis.Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation.[Stem cell transplantation for multiple sclerosis. Hamburg experiences and state of international research].Stem cells: Stemming the tide.
P2860
Q26823090-85AC156D-7EB3-4005-9D08-F2F3D7045F41Q31075436-AA61A9DE-F980-45F9-A5A6-0C0125F154FBQ33810097-5E19C99B-D302-4E95-B3C4-14542495D8F0Q34314312-A5EBF4E9-0534-494C-810B-681865B689CDQ34478828-9CE7FFAA-C628-483A-A853-2091576DB770Q36901406-3737634F-CCCC-4B3D-AC99-DE095AF592C4Q37003127-E211238A-F19F-4D83-9472-13FF7CFB0692Q37124529-98D01DF2-FC9C-46F3-BCAF-A815B6F2EF90Q37603718-8D34A540-FC0D-492D-BCF9-E71C02B3C022Q37673801-F04992E8-14AE-4F7B-9747-A2B9B62BAD2BQ38231123-67A1DC4D-E810-41E3-B981-211116003BB1Q38268313-79A9EBF8-35A9-44B0-A51D-75D3E8D49756Q38387292-CD62B474-3951-48E2-8981-5CDF92AA8607Q38636103-8453341C-8B18-4F34-B87B-D326EE2E2470Q38666303-41B4DA91-B91F-43F8-A844-04A143CDE7E3Q38939585-A4F7CA7D-C334-41C9-AFE9-375AEB092E3DQ39233323-E66D5A84-7CA6-40A4-9EAB-4D19FF980FE4Q41010737-F5316AAE-F2E2-40BA-83D3-777CA4AA18C1Q41589813-79E41B00-D540-4860-ADB1-DBC97075BCD7Q41715953-AB78BCFF-2734-4A77-8A7D-6A86201916EDQ42091679-5E96DB7D-79CC-41E3-862F-74C3A0F9F1C2Q44621693-C8632CA5-DB05-4A10-93C6-8042D6AD419BQ44976822-7BB29388-94C9-48C0-B5A2-B4B0527F3F44Q45867293-8FC9FEF6-EAB5-45C2-A9D9-B8C1D084047AQ46301560-738BFB04-6408-4383-9EAE-93CB0211D50FQ47885870-A9B1A512-ED32-4042-9168-991E6D885190Q48048274-AE5868D2-0B33-4D0B-8DE8-DC03CB7BD050Q48271331-2B3E175A-734D-463A-80A4-7F059468BA2FQ48721170-75002821-0AF1-4D48-900F-59EFE51D1632Q48881267-B6076E1A-31BC-499B-A98B-C6DB4CDF8913Q51240973-7750D68D-282D-4849-ABC8-999C74E683E3Q52944830-FC25DC30-B274-47B8-BEC0-0746851E79ADQ52952017-A8B7190E-EC70-442F-B4EA-E46374CD4E83
P2860
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A prospective, randomized, con ...... e sclerosis: a position paper.
@ast
A prospective, randomized, con ...... e sclerosis: a position paper.
@en
type
label
A prospective, randomized, con ...... e sclerosis: a position paper.
@ast
A prospective, randomized, con ...... e sclerosis: a position paper.
@en
prefLabel
A prospective, randomized, con ...... e sclerosis: a position paper.
@ast
A prospective, randomized, con ...... e sclerosis: a position paper.
@en
P2093
P2860
P356
P1476
A prospective, randomized, con ...... e sclerosis: a position paper.
@en
P2093
Center for International Blood and Marrow Research
European Blood and Marrow Transplantation Group
G L Mancardi
HSCT in MS International Study Group
L M Griffith
M P Sormani
M Pasquini
P2860
P304
P356
10.1177/1352458512438454
P577
2012-03-01T00:00:00Z